Table 2 Tumor characteristics
|  | Pre-pandemic group (n = 132) | Pandemic group (n = 133) | p-value |
|---|---|---|---|
Incident cancers (%) | 105 (82) | 102 (79) | 0.529 |
Tumor site | |||
 Thyroid (%) | 8 (6.1) | 6 (4.5) | 0.573 |
 Tonsil (%) | 16 (12.1) | 11 (8.3) | 0.300 |
 Base of tongue (%) | 7 (5.3) | 14 (10.5) | 0.116 |
 Parotid (%) | 9 (6.8) | 7 (5.3) | 0.595 |
 Cheek (%) | 4 (3.0) | 9 (6.8) | 0.159 |
 Other (%) | 88 (66.7) | 86 (64.7) | 0.731 |
Tumor type | |||
 SCC | |||
  SCC NOS (%) | 40 (30.5) | 52 (33.1) | 0.639 |
  SCC p16 + (%) | 27 (20.6) | 29 (18.5) | 0.648 |
  cSCC (%) | 15 (11.5) | 11 (8.2) | 0.375 |
  EBV-associated (%) | 4 (3.1) | 3 (2.2) | 0.679 |
 Melanoma (%) | 6 (4.6) | 7 (5.2) | 0.808 |
 Other (%) | 39 (29.8) | 32 (23.9) | 0.279 |